Jin Hong

Jin Hong has a strong background in the pharmaceutical industry, with experience spanning multiple companies. They began their career at InterMune in 2002 as a Group Leader, where they worked until 2009. After that, Jin Hong joined Alios BioPharma Inc. as an Associate Director, where they stayed until 2014. At this point, they moved to The Janssen Pharmaceutical Companies of Johnson & Johnson, where they served as a Scientific Director for the Oligonucleotide Center of Excellence until 2018. Their most recent position is as a Senior Director of Oligonucleotide Biology at Aligos Therapeutics, which they joined in 2018.

Jin Hong completed their education in a chronological order as follows:

Jin Hong attended Fuzhou No.1 High School from 1979 until 1985. The degree name and field of study for this period are unknown.

From 1985 to 1989, Jin Hong studied at Peking University and obtained a Bachelor of Science (B.S.) degree in Cell Biology and Genetics.

Finally, from 1990 to 1995, Jin Hong pursued a Ph.D. at the University of Minnesota, specializing in Biochemistry.

No additional information about Jin Hong's education history beyond these details is provided.